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Abstract
Objective—We investigated self-reported occupational exposure to antineoplastic drugs, 
anesthetic gases, antiviral drugs, sterilizing agents (disinfectants), and X-rays and the risk of 
spontaneous abortion in U.S. nurses.
Study Design—Pregnancy outcome and occupational exposures were collected retrospectively 
from 8,461 participants of the Nurses’ Health Study II. Of these, 7,482 were eligible for analysis 
using logistic regression.
Results—Participants reported 6,707 live births, and 775 (10%) spontaneous abortions (<20 
weeks). After adjusting for age, parity, shift work, and hours worked, antineoplastic drug exposure 
was associated with a 2-fold increased risk of spontaneous abortion, particularly with early 
spontaneous abortion before the 12th week, and 3.5-fold increased risk among nulliparous women. 
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Exposure to sterilizing agents was associated with a 2-fold increased risk of late spontaneous 
abortion (12–20 weeks), but not with early spontaneous abortion.
Conclusion—This study suggests that certain occupational exposures common to nurses are 
related to risks of spontaneous abortion.
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INTRODUCTION
Over two million women are employed as nurses,1 representing 4% of all employed women 
in the US.2 Nurses are potentially exposed to several suspected reproductive hazards, 
including anesthetic gases, antineoplastic (chemotherapy) drugs, antiviral drugs, sterilizing 
agents (disinfectants), and X-rays (ionizing radiation).3–9 Though the nursing profession is a 
critical component of the health care system, the effect of commonly encountered 
occupational exposures on reproductive health remains unclear within this predominantly 
female occupation.
Many previous studies of nursing exposures and spontaneous abortion lack adequate 
numbers of exposed cases to allow adjustment for confounders. Even though awareness of 
hazardous drug exposure has increased, protocols to reduce exposure of health care 
personnel to these chemicals have been insufficient to eliminate the exposure.10, 11 To 
clarify previous study results, we investigated the association between reported occupational 
exposures and risk of spontaneous abortion among participants of the Nurses’ Health Study 
II.
MATERIALS AND METHODS
The Nurses’ Health Study II was established in 1989 as a prospective cohort study of 
116,430 U.S. nurses, aged 25 to 42, in 14 states. Participants completed mailed 
questionnaires regarding their medical and reproductive history at baseline and were sent 
follow-up questionnaires every two years. In the 2001 questionnaire, participants were asked 
if they had experienced at least one pregnancy since 1993 and had worked as a nurse during 
the most recent of those pregnancies. If so, participants were asked whether they would be 
willing to complete a mailed supplemental questionnaire regarding occupational activities 
during their most recent pregnancy.
Among the 101,681 respondents to the 2001 biennial questionnaire, 11,177 (11%) had a 
pregnancy since 1993 during which they worked as a nurse. Willingness to complete the 
supplemental survey was indicated by 9,547 (85%) participants; 8,461 (89%) of these 
women completed and returned the supplemental survey they were mailed, resulting in an 
overall participation rate of 76% for the supplement. Since multiple pregnancies per woman 
are not independent events, we asked only about the most recent pregnancy.
Pregnancies ending in an induced abortion (n=147), ectopic pregnancy (n=57), molar 
pregnancy (n=13), or multiple pregnancy (n=235), as well as 7 pregnancies with a missing 
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pregnancy outcome, were excluded. Stillbirths, defined as a pregnancy loss after 20 weeks 
gestation, were also excluded (n=42). Pregnancies were excluded if the participant reported 
that the pregnancy was not confirmed by a clinical or over-the-counter pregnancy test 
(n=130), as well as pregnancies without data on the year the pregnancy ended (n=31) or the 
length of the pregnancy (n=22). Women who reported working less than 1 hour per week as 
a nurse during the first trimester of pregnancy (n=65); or who did not provide information 
on shift work (n=24), anesthetic gases (n=19), sterilizing agents (n=91), antineoplastic drugs 
(n=14), antiviral drugs (n=33), or X-rays (n=49); were also excluded. In total, 979 (11.6%) 
women were excluded, leaving data on 7,482 women in the analysis.
For each trimester of pregnancy, the following questions were asked: “On average how 
many hours per day did you work with the following agents:” and the following categories, 
with examples, were given “a. Anesthetic gases (e.g. nitrous oxide, halothane, enflurane, 
isoflurane),” “b. Anti-cancer drugs (e.g. Cytoxan, Fluroplex, Adrucil, Etoposide, 5-FU),” “c. 
Anti-viral drugs (e.g. Gancyclovir or the interferons),” “d. Sterilizing agents (e.g. ethylene 
oxide, formaldehyde, glutaraldehyde),” and “e. X-ray radiation.” Data on work schedule, 
night work, average hours worked per week, frequency of lifting 25 pounds or more at work, 
hours per day of standing or walking at work, smoking, alcohol consumption, and caffeine 
consumption were also collected for each trimester of pregnancy. From the main biennial 
questionnaires, data were also available on age, race/ethnicity, body mass index (BMI), 
medication use, parity, and prior spontaneous abortion.
Participants reported the outcome of the index pregnancy as a single live birth, stillbirth, 
twins, triplets+, induced abortion, tubal/ectopic pregnancy, miscarriage, or molar pregnancy. 
Categorical information on pregnancy duration was reported on the supplemental survey as 
weeks since last menstrual period (less than 8, 8–11, 12–19, 20–23, 24–27, 28–31, 32–36, 
37–41 (full-term), and 42 or more weeks). Pregnancies ending involuntarily before 20 weeks 
gestation were classified as spontaneous abortions.
Completion of the self-administered questionnaire was considered implied informed 
consent. The study and informed consent procedure were approved by the Institutional 
Review Board of the Brigham and Women’s Hospital.
Descriptive statistics (frequency, range, and age-adjusted means) were calculated for 
selected maternal characteristics. The relationship between spontaneous abortion and first-
trimester exposure to anesthetic gases, antineoplastic agents, sterilizing agents, antiviral 
drugs, and X-rays was examined in univariable and multivariable analyses. We modeled age 
as a continuous variable. Because the risk of spontaneous abortion rose exponentially with 
age, we also included a quadratic age term (age-squared) in the models. Exposure categories 
were dichotomized as 1+ hour per day versus <1 hour per day for all reported exposures.
For univariable and multivariable analyses, we used logistic regression to compute the odds 
ratio (OR) using SAS software. Covariates that changed the estimate by 10% or more were 
retained in the final multivariate model.
We first considered the associations of these individual exposures with risk of spontaneous 
abortion, adjusted for age. Our full multivariable model included all 5 work exposures of 
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interest, age, parity, and work schedule. The addition of lifestyle and other factors, such as 
cigarette smoking, caffeine consumption, alcohol consumption, BMI, race/ethnicity, lifting 
at work, and standing at work did not change the estimated effects by more than 10%. 
Because previous occurrence of spontaneous abortion could have been due to the same 
environmental or occupational exposures studied in the index spontaneous abortion, and to 
avoid possible bias, we did not adjust for previous spontaneous abortion in these analyses.12 
Our primary analysis looked at all spontaneous abortions as the outcome. In our secondary 
analysis, we stratified by the timing of the spontaneous abortion, since early and late 
spontaneous abortion may be controlled by different mechanisms, and the percentage of 
spontaneous abortions due to chromosomal abnormalities decreases as gestational age 
increases.13 For this analysis, early spontaneous abortion is modeled as <12 weeks gestation, 
and late spontaneous abortion as 12–20 weeks. For the analysis of late spontaneous 
abortions, early spontaneous abortions were excluded (n=575). To assess statistically 
significant differences between early and late models, we calculated p-values for common 
effects with a chi-square test statistic using the maximum likelihood estimates from the 
logistic regression. We also assessed interactions between parity and each exposure by 
modeling a cross-product interaction term in a model containing the main effects of parity 
and the exposure, as well as other covariates.
RESULTS
Among 7,482 eligible participants, the pregnancies of 775 (10%) ended in spontaneous 
abortion. Seventy-four percent of those ended before the 12th week of pregnancy (n=575). 
The year of the pregnancies ranged from 1993–2002 (the mean year was 1996), with 82% 
occurring between 1993 and 1998. The spontaneous abortion rate varied by specialty area; 
the lowest rates were for medical/surgical and critical care (8.4% and 8.8%, respectively), 
and the highest rates for home health/community and oncology (13.1% for each). However, 
32% of nurses specified “other” as their specialty area (11.0% spontaneous abortion rate).
Table 1 shows age-adjusted prevalence of selected characteristics of eligible participants by 
pregnancy outcome. Women whose pregnancies ended in spontaneous abortion were older 
and less likely to be parous than those with live births. Prior spontaneous abortion, higher 
consumption of caffeinated beverages and alcohol, and cigarette smoking were also more 
common among pregnancies ending in spontaneous abortion. Occupational exposures were 
reported more often in spontaneously aborted pregnancies, particularly exposure to 
antineoplastic drugs - which was reported nearly twice as often compared to live births 
(Table 2). As previously reported,14 women whose pregnancies failed were more likely to 
have worked the night shift and to have worked long hours during the first trimester than 
women with live births.
Table 3 provides estimated odds ratios and 95% confidence intervals (95%CI) for the 
associations between occupational exposures and spontaneous abortion in three models. 
First, we evaluated the associations between each individual exposure and spontaneous 
abortion (adjusted for age), showing increased risks for spontaneous abortion with reported 
exposure to antineoplastic drugs, sterilizing agents, and X-rays. When simultaneously 
adjusting for age and all five work exposures, these three exposures were still associated 
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with spontaneous abortion, though X-ray exposure was of borderline statistical significance. 
Further adjustment for parity, shift work, and hours worked per week had modest impact, 
and showed that nurses reporting occupational exposure to antineoplastic drugs had a 94% 
increased risk of spontaneous abortion, while exposure to sterilizing agents had a 39% 
increased risk. To evaluate if exclusion of pregnancies not confirmed by a pregnancy test 
resulted in any bias, we analyzed the final model without this exclusion, and the results were 
nearly identical.
Because nulliparous women might have underlying sub-fertility that may make them more 
susceptible to effects of reproductive hazards, we conducted a secondary analysis by parity. 
We evaluated the multiplicative interaction between each exposure and parity (yes/no), 
adjusted for age, shift work, hours worked, and each of the occupational exposures. There 
were 240 (19.2%) spontaneous abortions among the 1,249 nulliparous women and 535 
spontaneous abortions among the 6,233 parous women (8.9%). Only antineoplastic drugs 
appeared to interact with parity (interaction p=0.04), with stronger associations among 
nulliparas (3.50, 95% CI 1.79–6.87) than among parous women (1.44, 0.88–2.36)
Because early spontaneous abortions may have different etiologies than later pregnancy 
loss,13 we conducted a sub-analysis stratified by gestational age of the pregnancy for early 
loss (less than 12 weeks gestation, n=575) versus late loss (12–20 weeks gestation, n=200). 
The results-- adjusted for all work exposures, age, parity, shift work and hours worked per 
week-- are shown in Table 4. The stratified analysis shows that reported exposures to 
antineoplastic drugs [OR=2.13 (95%CI= 1.39–3.27)] and, to a lesser extent, X-rays 
[OR=1.31 (95%CI= 1.01–1.71)] were associated with an increased risk for early pregnancy 
loss. Reported exposure to sterilizing agents was associated with later pregnancy loss 
[OR=2.10 (95%CI= 1.29–3.41)] but not with early spontaneous abortion; the difference 
between the two models was statistically significant (p-value = 0.04).
COMMENT
We found that exposure to some of the agents commonly used by health care workers, 
including antineoplastic drugs, sterilizing agents, and X-rays, were associated with an 
increased risk of spontaneous abortion. Antineoplastic drugs are handled by nurses, 
pharmacists, physicians, operating room personnel, workers in veterinary practices, and 
manufacturers; exposures can occur during manufacture, preparation, administration, and 
contact with patient waste products.15 Recognized as teratogenic and mutagenic, 
antineoplastic agents act on rapidly proliferating cells and are therefore of particular concern 
for a developing fetus.16–18 Previous studies have had mixed results, and many suffer from 
limited sample sizes. The three largest studies19–21 showed increased risks for spontaneous 
abortion with self-reported first trimester exposure through handling or mixing, mostly 
among oncology nurses or pharmacists (ORs ranging from 1.5–2.3) in samples that included 
from 18 to 223 exposed cases. Other studies did not find statistically significant 
associations22–27 with ORs ranging from 0.7– 2.8, and limited sample sizes (3 to 34 exposed 
cases). A meta-analysis pooled the results of five studies19–21, 24, 25 and found an overall 
adjusted increased risk of 46% (95% CI = 11%–92%).28 Only one of these studies25 
occurred after safe handling measures were first recommended in 1985.29, 30 However, since 
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1985, several exposure studies still report drug contamination on work surfaces in 
pharmacies and patient rooms.31 NIOSH recently updated the recommendations for safe 
handling of antineoplastic drugs.32
Our findings regarding exposure to sterilizing agents is consistent with our previously 
reported association of sterilizing agents with risk of preterm birth (RR=1.9, 95% CI = 1.1–
3.4).33 Glutaraldehyde, formaldehyde, ethylene oxide, orthophthalaldehyde, peracetic acid, 
and hydrogen peroxide are used to disinfect medical equipment and surgical instruments. 
Ethylene oxide and formaldehyde are recognized as carcinogenic and mutagenic, but there 
have been few studies in humans to evaluate their reproductive toxicity,3, 34, 35 and most had 
limited sample sizes. Information regarding safe exposure levels for pregnant women is 
lacking. Future studies should build on these findings to clarify which specific sterilizing 
agents may pose risks to pregnant nurses, the specific context in which they are being used, 
and the efficacy of safe handling practices.
Though it is well-known that an acute dose of ionizing radiation is a reproductive hazard, 
the reproductive risks associated with occupational exposure to X-rays during pregnancy are 
not well defined.36 The current occupational exposure limit for ionizing radiation to the 
fetus of a pregnant worker is 5 mSv (0.5 rem) cumulative during the course of the 
pregnancy, with a monthly equivalent dose limit of 0.5 mSv.37 Factors associated with the 
level of radiation include the source, distance from the source, use of a shielded control 
booth or leaded apron, and gestational age at the time of exposure. Health care workers, 
dental assistants, and veterinarians can be exposed via X-rays, CT scans, fluoroscopies, 
radioactive isotopes, and radioactive implants; these are listed in order of increasing relative 
biological effectiveness. A recent study found a 3-fold higher spontaneous abortion rate 
among women occupationally exposed to radioisotopes compared to X-rays,38 suggesting a 
dose-response relationship. In addition, staff who use mobile X-ray machines may find it 
difficult to follow guidelines to reduce exposure.7 A radiation safety officer can advise 
workers on atypical or nonstandard procedures where radiation exposure is unavoidable.
Anesthetic gases have long been of concern to nurses, dental workers, and veterinarians, 
though our study did not show an association with spontaneous abortion. 6, 39 A meta-
analysis of studies that were conducted in the absence of scavenging systems reported 
increased risks for spontaneous abortion.40 Studies of dental and veterinary offices have 
found increased risks of spontaneous abortion in practices where anesthetic gases were not 
scavenged.41, 42 More recent studies show inconsistent results, possibly due to sample size 
limitations42–44 or due to the heterogeneity of exposure. While appropriate engineering 
controls are commonplace in many hospital operating rooms, smaller medical facilities 
(such as dental, veterinary, or pediatric offices) may be less vigilant in controlling 
exposures. In addition, reduced ability of pediatric patients and veterinary animals to 
voluntarily cooperate during gas administration procedures could hamper the effectiveness 
of scavenging. Therefore, though our study supports the idea that the use of engineering 
controls has reduced the risk of spontaneous abortion, it does not rule out possible effects on 
pregnancy in smaller facilities.
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We could find no previous studies of occupational exposure to antivirals and spontaneous 
abortion. Because certain antivirals are considered to be teratogenic to animals, and are 
contraindicated during pregnancy according to the FDA, pregnant health care workers 
should be advised of potential risks when administering aerosolized antivirals.45
Though recall error is a potential limitation of our study, we attempted to minimize it by 
keeping the recall period relatively short (<= 8 years, mean of 5 years).46 In addition, 
Nurses’ Health Study participants have been shown to self- report health data accurately for 
several medical conditions.47–49 Moreover, self-report of the duration of drug handling by 
pharmacists has been shown to be valid.50
However, there is still potential for recall bias, since the pregnancy outcomes were reported 
on the same instrument that collected occupational exposures. Though we cannot directly 
measure recall bias, we do not believe it is likely to explain our findings. First, we observed 
substantially different odds ratios for early versus late spontaneous abortions for 
antineoplastic agents and sterilizing agents. This observation is consistent with biological 
mechanisms, and it is not expected that recall bias would be differential based on whether 
the spontaneous abortion was early or late. In addition, we would expect recall bias to be 
highest for agents with the most awareness of potential hazard,51 such as X-rays;52 however, 
we noted only a small excess risk associated with exposure to X-rays.
An important limitation of our study is that we were not able to collect information on 
measures to control exposures, such as use of gloves, respirators, lead aprons, ventilation, or 
scavenging systems; nor did we collect information on types of agents being used, forms of 
administration, or sources of radiation. Future studies could improve on the current study 
with a more detailed exposure assessment instrument; such data are currently being 
collected in the Nurses’ Health Study III.
The large sample size, narrow recall period, and ability to control for multiple exposures are 
improvements over previous studies. Though the homogeneity of the nurses in our study 
with respect to socio-economic status and education may decrease generalizability, it also 
likely reduced confounding. Unlike previous studies, we were also able to distinguish 
between early and late spontaneous abortions, which likely follow different mechanisms and 
etiologies, with early spontaneous abortions having a higher likelihood of being due to 
chromosomal abnormalities.13 Therefore, it is possible that earlier spontaneous abortions 
could be due to exposures which are mutagenic, whereas later spontaneous abortion may be 
the result of teratogenic exposures or exposures that affect the mother’s ability to carry the 
infant to term. Further research is indicated to explore the differences we see in our data.
In conclusion, we found increased risks for spontaneous abortion with reported exposures to 
antineoplastic drugs, sterilizing agents, and X-rays. Although antineoplastic drugs and X-
rays are known reproductive hazards, U.S. nurses are still reporting exposures to these 
during pregnancy. We encourage nurses who are pregnant, or who wish to become pregnant, 
to work with their employers and their health care providers to reduce exposures during 
pregnancy and lactation.
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Table 1
Demographic and lifestyle factorsa by pregnancy outcome.




Maternal pre-pregnancy BMIb 25.3, 16.1–50.0 (5.7) 24.3, 15.0 – 50.0 (4.9)
Mean, range, (SD)
Maternal Age 39.5, 30–51 (3.8) 36.4, 29–50 (3.4)
Mean, range, (SD)
n % n %
Maternal age category
 <=30 6 0.8 175 2.6
 31–35 112 14.5 2,609 38.9
 36–40 (referent) 344 44.4 3,113 46.4
 41+ 313 40.4 810 12.1
Race
 African Americanc 5 0.4 42 0.7
 Asian 12 1.1 119 1.9
 Caucasian 719 92.5 6,229 92.8
 Hispanic 11 1.3 101 1.5
 Other 15 2.2 100 1.5
 Missing 13 2.5 116 1.7
 Parous 535 68.2 5,698 84.6
 Previous spontaneous abortion 394 44.9 2,296 34.9
First Trimester Lifestyle Factors
Caffeinated coffee servingsd
 None (reference) 412 55.1 4,151 61.6
 <=1 cup per day 232 28.8 1,874 28.1
 >=2 cups per day 130 15.8 676 10.2
 Missing 1 0.4 6 0.1
Caffeinated soda/tea servingsd
 None (reference) 379 45.7 3,191 47.9
 <=1 serving per day 284 38.4 2,781 41.2
 >=2 servings per day 112 15.9 720 10.7
 Missing 0 0.0 15 0.2
Alcoholic beverage servingsd
 None (reference) 584 76.8 5,459 81.2
 <1 drink per week 120 14.8 926 13.9
 >=1 drink per week 70 8.3 315 4.8
 Missing 1 0.1 7 0.1
Smoked cigarettes per day
 None (reference) 710 92.2 6,316 94.2
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 >=1 cigarette per day 65 7.6 389 5.8
 Missing 0 0.0 2 0.0
a
Percentages for all variables except maternal age are directly standardized by year of age at current pregnancy
b
Body Mass Index (kg/m2) recorded on the most recent questionnaire prior to the current pregnancy
c
101 participants were missing data on race.
d
Servings of caffeinated/alcoholic beverages = 8 oz coffee, 12 oz soda, 8 oz hot tea, 16 oz iced tea, 12 oz beer, 6 oz wine, 1 oz liquor













LAWSON et al. Page 13
Table 2
Occupational factorsa by pregnancy outcome.





“On average, how many hours per day did you work with the following agents:”
“Anesthetic gases (e.g. nitrous oxide, halothane, enflurane, isoflurane)?”
 <1 (reference) 706 90.6 6,133 91.5
 1–4 30 3.9 234 3.5
 4–8 29 4.3 274 4.1
 9+ 10 1.2 66 1.0
“Anti-cancer drugs (e.g., Cytoxan, Fluroplex, Adrucil, Etoposide, 5-FU)?”
 <1 (reference) 727 92.8 6,453 96.2
 1–4 39 5.8 202 3.0
 4–8 8 1.3 45 0.7
 9+ 1 0.1 7 0.1
“Anti-viral drugs (e.g., Gancyclovir) or the interferons?”
 <1 (reference) 724 93.1 6,333 94.5
 1–4 45 6.2 354 5.2
 4–8 6 0.8 16 0.2
 9+ 0 0.0 4 0.1
“Sterilizing agents (e.g., ethylene oxide, formaldehyde, glutaraldehyde?”
 <1 (reference) 699 90.7 6,210 92.7
 1–4 68 8.5 435 6.4
 4–8 8 0.7 51 0.7
 9+ 0 0.0 11 0.2
“X-ray radiation?”
 <1 (reference) 650 81.5 5,781 86.3
 1–4 116 17.1 852 12.6
 4–8 8 1.2 61 0.9
 9+ 1 0.2 13 0.2
Work Scheduleb
“What schedule did you usually work? If most of work hours are 
between 8 am-4pm, then it is “day”; if 4pm-midnight, then it is 
“evening”; if midnight-8am, then it is “night.”
Shift
 Days only (reference) 536 66.7 4,573 68.6
 Nights only 89 12.7 575 8.5
 Rotating shifts including nights 54 7.4 433 6.4
 Day/Evening rotating; no nights 96 13.2 1,126 16.5
Hours worked (hours/week)
 1 – 20 158 24.7 1,707 25.2
 21 – 40 397 49.0 3,846 57.4
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 41+ 220 26.2 1,154 17.4
a
Percentages for all variables except maternal age are directly standardized by year of age at current pregnancy
b
Trimester-specific occupational exposures and work schedule were collected by questionnaire.
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Table 3
Association between occupational exposures during the first trimester and spontaneous abortion
Occupational Exposures Odds Ratio (95% Confidence Interval)
Age-adjusted Modelsa Combined Exposuresb Full Modelc
Anesthetic gases
 <1 hour per day (reference) 1.0 1.0 1.0
 1+ hours per day 1.07 (0.81–1.40) 0.85 (0.63–1.17) 0.88 (0.65–1.21)
Antineoplastic agents
 <1 hours per day (reference) 1.0 1.0 1.0
 1+hours per day 1.97 (1.41–2.76) 2.03 (1.39–2.97) 1.94 (1.32–2.86)
Antiviral agents
 <1 hours per day (reference) 1.0 1.0 1.0
 1+ hours per day 1.28 (0.93–1.76) 0.93 (0.65–1.34) 0.92 (0.64–1.32)
Sterilizing agents
 <1 hour per day (reference) 1.0 1.0 1.0
 1+ hours per day 1.46 (1.12–1.91) 1.46 (1.09–1.95) 1.39 (1.03–1.87)
X-ray radiation
 <1 hour per day (reference) 1.0 1.0 1.0
 1+ hours per day 1.31 (1.05–1.62) 1.27 (1.01–1.60) 1.22 (0.97–1.55)
a
The Age-adjusted Model evaluated each exposure independently, adjusting for age
b
The Combined Exposures Model tested each work exposure with all work exposures, adjusting for age
c
The Full Model includes all work exposures, adjusting for age, parity, shift work, and hours worked.
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Table 4
Association between occupational exposures during the first trimester and early versus late spontaneous 
abortion
Occupational Exposures Odds Ratio (95% Confidence Interval)
Early Spontaneous Abortion (<12 
weeks)a
n=575
Late Spontaneous Abortion (12–20 
weeks) a,b
n=200
Difference of effect 




 <1 hour per day (reference) 1.0 1.0
 1+ hours per day 0.94 (0.66–1.33) 0.79 (0.44–1.42) 0.6
Antineoplastic agents
 <1 hours per day (reference) 1.0 1.0
 1+ hours per day 2.13 (1.39–3.27) 1.39 (0.68–2.84) 0.3
Antiviral agents
 <1 hours per day (reference) 1.0 1.0
 1+ hours per day 0.76 (0.50–1.18) 1.35 (0.75–2.44) 0.1
Sterilizing agents
 <1 hour per day (reference) 1.0 1.0
 1+ hours per day 1.13 (0.80–1.60) 2.10 (1.29–3.41) 0.04
X-ray radiation
 <1 hour per day (reference) 1.0 1.0
 1+ hours per day 1.31 (1.01–1.71) 0.98 (0.63–1.53) 0.3
a
Adjusted for all work exposures, age, parity, shift work categories, and hours worked per week.
b
Excludes the 575 pregnancies ending in early spontaneous abortion
c
To assess statistically significant differences between early and late spontaneous abortion models, we calculated p-values for common effects with 
a chi-square test statistic using the maximum likelihood estimates from the logistic regressions.
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